Data through FY2026 Q3 (Jun 30, 2026)
Aurobindo Pharma USA, Inc.
Company profile for Aurobindo Pharma USA, Inc. covers 22 filings across the reporting window. FY2026 certified median offer: $141,349.
- FY2026 certified median
- $141,349
- Total filings
- 22
- FY2026 25th–75th percentile
- $111,000–$215,519
- Top job title
- ASSOCIATE DIRECTOR, CORPORATE FINANCE
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 4 | $116,800 | $107,450 | $160,250 |
| FY2025 | 12 | $97,150 | $76,622 | $108,000 |
| FY2026 (Q1–Q3) | 6 | $141,349 | $111,000 | $215,519 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- ASSOCIATE DIRECTOR, CORPORATE FINANCE2 filings
- Financial and Investment Analyst2 filings
- ANALYST / BUSINESS1 filings
- Assistant Manager--Demand Planning1 filings
- Assistant Manager, Finance1 filings
- Assistant Manager, Supply Chain1 filings
- Associate Director, Finance1 filings
- Automation Engineer1 filings
- Chief Financial Officer1 filings
- Compliance Officer1 filings
Top cities
- East Windsor11 filings
- E. Windsor8 filings
- Durham2 filings
- Naranja1 filings